BIVALIRUDIN INJECTION
BIVALIRUDIN INJECTION
Approved
DIN Number
02505517
Drug Class
Human
Market Date
Mar 5, 2021
Company
HC
avir pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505517
AIG Number0148342002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AE06 BIVALIRUDIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:12.04.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
BIVALIRUDINActive
Strength: 5 MG / ML
Monograph: BIVALIRUDIN